Impact of the Sasang Constitutional Type on the High-Sensitivity C-Reactive Protein, a Predictor of Cardiovascular Disease
![]() |
Kang, Mi-Jeong
(Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Kyung Hee University)
Lee, Ji-Won (Kyung Hee University) Lee, Eui-Ju (Kyung Hee University) Koh, Byung-Hee (Kyung Hee University) Lee, Jun-Hee (Kyung Hee University) |
1 | Han Ks, Lee HE, Lee JY, Ahn TW. A study of relationship between coronary heart disease risk and Sasang Constitution based on NCEP-ATPIII. J Sasang Constitut Med. 2008;20(3):94-106. |
2 | Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the Am Heart Association. Circulation. 2003;107:499-511. DOI ScienceOn |
3 | Available from:URL:http://kostat.go.kr/portal/korea/index. action. |
4 | Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant D, for the Conference Participants. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438. DOI ScienceOn |
5 | Lee SW. Jang ES. Lee J, Kim JY. Current researches on the methods of diagnosing sasang constitution: an overview. Evid Based Complement Alternat Med. 2009;6 Suppl 1:43-9. DOI |
6 | Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Excutive summary of the third report of the National Cholesterol Education Program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ). JAMA. 2001;285:2486-2497. DOI ScienceOn |
7 | Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cut off points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75(1):72-80. DOI ScienceOn |
8 | Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):13-18. DOI |
9 | Wannamethee SG, Shaper G, Lennon L, Morris RW. Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus. Arch Intern Med. 2005;165: 2644-2650. DOI ScienceOn |
10 | Casas JP, Shah T, Higorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264(4):295-314. DOI ScienceOn |
11 | Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, et al. LL. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(7):496-507. DOI ScienceOn |
12 | Roberts WL, Sedrick R, Moulton TKL, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem. 2000;46(4): 461-8. |
13 | Yang SM, Yoo JS, Koh SB, Park JK. Association between risk factors and prevalence of Metabolic Syndrome according to Sasang Constitution in Wonju cohort study. J Sasang Constitut Med. 2009;21(1):186-196. (Korean). |
14 | Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1982;97(18):1837-47. |
15 | Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, et al. C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population. Arterioscler Thromb Vasc Biol. 2004;24:1509-1515. DOI ScienceOn |
16 | Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-207. DOI ScienceOn |
17 | Chol JY, Park SS. A clinical study for 157 cases of CVA by Sasang Constitutional Medicine. J Sasang Constitut Med. 1998;10(2):431-453. |
18 | Spatz ES, Canavan ME, Desai MM. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2009;2(1):41-8. DOI |
19 | Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem. 2008;54(6):1027-37. DOI ScienceOn |
20 | Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol. 2008;28(7):1385-91. DOI ScienceOn |
21 | Ham TI. The prevalence and risk factors of the Metabolic Syndrome according to Sasang Constitution in middle aged persons. Dept of Oriental Medicine, Graduate school, Kyunghee University, Seoul, Korea.(Korean). |
22 | Lee TG. Koh BH. Lee, SK. Sasang constitution as a risk factor for diabetes mellitus: a cross-sectional study. Evid Based Complement Alternat Med. 2009;6(1):99-103. DOI |
23 | Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-32. DOI ScienceOn |
24 | Kim HJ, Pae SW, Kim DJ, Kim SK, Kim SH, Rhee YM, et al. Association of serum high sensitivity C-reactive protein with risk factors of cardiovascular disease in type 2 diabetic and nondiabetic subjects without cardiovascular diseases. The Korean Journal of Medicine. 2002;63(1):35-45.(Korean) |
25 | Dep. of Sasang Constitutional Medicine of Kyung Hee University. The manual of Dep. of Sasang Constitutional Medicine (subtitle: reference book of Sasang Constitutional Medicine). Seoul:Hanmibook. 2010.(Korean), |
26 | Yeo HR, Kim KK, Lee MH, Park Yc, Jeon SH, Kwon SD, et al. A study on the Sasang Constitutional characterisitcs by Obesity Grade. J Sasang Constitu Med. 2008;20(1):89-99.(Korean). |
27 | Jang HS. The study on Odds Ratio of Dyslipidemia in Different Constitutional Types. Dept of Oriental Medicine, Graduate school, Kyunghee University, Seoul, Korea.(Korean). |
28 | Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347: 1557-1565. DOI ScienceOn |
29 | van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med. 2003;163(11): 1323-8. DOI ScienceOn |
30 | Seok JH, Km U, Lee SH, Hong GR, Park JS, Shin DG et al. Correlations of C-reactive protein levels and Frammingham coronary risk score. The Korean Journal of Medicine. 2007;73(3):36-45.(Korean). |
31 | Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(Suppl 6A):9-16. DOI |
32 | Lee TG, Lee SK, Choe BK, Song IB. A study on the prevalence of chronic diseases according to Sasang Constitution at a health examination center. J Sasang Constitut Med. 2005;17(2):32-45.(Korean). |
33 | Choi KJ, Lee Jh, Yoo JH, Lee EJ, Koh BH. Sasang constitutional types can act as a risk factor for insulin resistance. Diabetes Res Clin Pract. 2011;91(3):57-60. DOI ScienceOn |
34 | Han KS, Bae NY, Lee HE, Ahn TW. A study of relationship between blood chemical risk factor of cardiovascular disease and Sasang Constitution and effect of Oxygen Free Radical on the relationship. J Sasang Constitut Med. 2007;19(2):143-154.(Korean) |
35 | Hwang YC, Jee JH, Oh EY, Choi YH, Lee MS, Kim KW, Lee MK. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int J of Cardiology. 2009;134:313-321. DOI ScienceOn |
36 | Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can Fam Physician. 2011;57(4):417-23. |
37 | Buckley DI, Fu R, Freeman M, Rogers K, Hefand M. C-reactive protein as a risk factor for coronary heart disease: A systematic review and Meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(7):483-495. DOI ScienceOn |
38 | Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ.Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ.Eur Heart J. 2010;31(17): 2087-91. DOI ScienceOn |
39 | Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J. 2010;31(17): 2092-6. DOI ScienceOn |
40 | Shim GH, YOo JS, Koh SB, Park JK. A study on the relationship between Sasang Constitution and Framingham Coronary Risk Score. J Sasang Constitut Med. 2009;21(1):165-185.(Korean). |
![]() |